Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Acute Respiratory Failure-I01:21

Acute Respiratory Failure-I

Acute respiratory failure is a condition characterized by the inability of the lungs to perform their primary function: gas exchange. This failure leads to insufficient oxygen levels (hypoxemia) in the blood, elevated carbon dioxide levels (hypercapnia), or both, causing critical impairment in organ function.
Definition: It is defined by specific criteria based on blood gas measurements. Hypoxemia happens when the partial pressure of oxygen (PaO2) falls below 60 mmHg. At the same time,...
Acute Respiratory Failure-II01:21

Acute Respiratory Failure-II

Type I Respiratory Failure, or hypoxemic respiratory failure, occurs when the partial pressure of oxygen (PaO2) in arterial blood falls below 60 mmHg while breathing room air without a corresponding increase in arterial carbon dioxide levels (PaCO2). This condition highlights a significant impairment in the lungs' capacity to oxygenate the blood.
The underlying physiological abnormalities that contribute to hypoxemic respiratory failure include:
Acute Respiratory Failure-III01:30

Acute Respiratory Failure-III

Hypercapnic respiratory failure, also known as Type 2 or ventilatory respiratory failure, is a severe condition characterized by the body's inability to effectively remove carbon dioxide (CO2) from the bloodstream. It leads to an arterial CO2 pressure (PaCO2) exceeding 45 mmHg and a blood pH above 7.35. This situation indicates that the body's ventilatory demand, or the ventilation needed to maintain normal PaCO2 levels, surpasses its supply or the maximum gas flow achievable without causing...
Acute Respiratory Failure-IV01:23

Acute Respiratory Failure-IV

Respiratory failure can manifest suddenly or gradually, characterized by a rapid decline in PaO2 and a rapid rise in PaCO2. This situation indicates a severe respiratory problem that may quickly become a life-threatening emergency. One of the early signs of hypoxemic Acute Respiratory Failure (ARF) is a change in mental status due to the brain's sensitivity to oxygen levels and changes in acid-base balance. Symptoms such as restlessness, confusion, and agitation suggest inadequate oxygen...
Acute Respiratory Failure-V01:29

Acute Respiratory Failure-V

The treatment for acute respiratory failure varies based on factors like the underlying cause, overall health, and severity. A collaborative healthcare team is essential for early detection, often through arterial blood gas analysis. Identifying the cause is the primary goal, with treatment strategies adjusted for ventilation/perfusion (V/Q) mismatch, shunting, or diffusion impairment.
Ensure that patients are monitored continuously for their response to therapy, including changes in...
Myasthenia Gravis ll: Pathophysiology01:22

Myasthenia Gravis ll: Pathophysiology

The disease process of myasthenia gravis begins at the neuromuscular junction, where antibodies attack key proteins needed for muscle activation. This immune reaction weakens signal transmission, leading to the characteristic muscle fatigue and weakness that define the condition.Immune-Mediated DamageIn most individuals, antibodies target acetylcholine receptors (AChRs) on the postsynaptic membrane of muscle cells. By blocking acetylcholine binding, these antibodies prevent the nerve signal...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

The early impact of the COVID-19 pandemic on international fellows.

Critical care science·2026
Same author

Dyspnea as a marker of prognosis in immunocompromised patients with acute respiratory failure.

Annals of intensive care·2026
Same author

Gender equality and equity in intensive care: an international Delphi consensus study.

Intensive care medicine·2026
Same author

Sex-Specific Differences in Tidal Volumes and Mortality of Mechanically Ventilated Patients.

Critical care medicine·2026
Same author

Considerations for environmental sustainability in clinical trials: A case study simulation of the REVISE trial.

Journal of critical care·2026
Same author

Executive Summary: Society of Critical Care Medicine Guidelines for the Administration of Neuromuscular Blockade in Adults With Acute Respiratory Distress Syndrome.

Critical care medicine·2026

Related Experiment Video

Updated: May 20, 2026

Functional and Morphological Assessment of Diaphragm Innervation by Phrenic Motor Neurons
09:43

Functional and Morphological Assessment of Diaphragm Innervation by Phrenic Motor Neurons

Published on: May 25, 2015

Neuromuscular disease causing acute respiratory failure.

Sangeeta Mehta1

  • 1Interdepartmental Division of Critical Care Medicine, Mount Sinai Hospital, 600 University Avenue, Toronto, Ontario, M5G 1X5, Canada. geeta.mehta@utoronto.ca

Respiratory Care
|August 29, 2006
PubMed
Summary

Guillain-Barré syndrome and myasthenia gravis are leading causes of acute respiratory failure in neuromuscular disease. Early assessment and pulmonary function tests predict the need for mechanical ventilation, crucial for patient outcomes.

More Related Videos

Measuring Neuromuscular Junction Functionality
10:40

Measuring Neuromuscular Junction Functionality

Published on: August 6, 2017

Repeated Measurement of Respiratory Muscle Activity and Ventilation in Mouse Models of Neuromuscular Disease
09:24

Repeated Measurement of Respiratory Muscle Activity and Ventilation in Mouse Models of Neuromuscular Disease

Published on: April 17, 2017

Related Experiment Videos

Last Updated: May 20, 2026

Functional and Morphological Assessment of Diaphragm Innervation by Phrenic Motor Neurons
09:43

Functional and Morphological Assessment of Diaphragm Innervation by Phrenic Motor Neurons

Published on: May 25, 2015

Measuring Neuromuscular Junction Functionality
10:40

Measuring Neuromuscular Junction Functionality

Published on: August 6, 2017

Repeated Measurement of Respiratory Muscle Activity and Ventilation in Mouse Models of Neuromuscular Disease
09:24

Repeated Measurement of Respiratory Muscle Activity and Ventilation in Mouse Models of Neuromuscular Disease

Published on: April 17, 2017

Area of Science:

  • Neurology
  • Pulmonology
  • Critical Care Medicine

Background:

  • Guillain-Barré syndrome (GBS) and myasthenia gravis (MG) are primary neuromuscular disorders causing acute respiratory failure.
  • Respiratory failure in these conditions results from upper-airway dysfunction, inspiratory and expiratory muscle weakness, and secondary pulmonary complications.

Purpose of the Study:

  • To review the mechanisms of acute respiratory failure in GBS and MG.
  • To outline clinical assessment strategies and predictors for mechanical ventilation.
  • To discuss intensive care unit (ICU) morbidity and mortality in mechanically ventilated patients with GBS or MG.

Main Methods:

  • Review of existing literature on GBS, MG, and acute respiratory failure.
  • Analysis of clinical assessment techniques and pulmonary function tests (PFTs).
  • Examination of ICU outcomes, including morbidity and mortality.

Main Results:

  • Key components of respiratory failure include muscle weakness and pulmonary complications.
  • Pulmonary function tests such as vital capacity, peak inspiratory pressure, and peak expiratory pressure aid in predicting ventilation needs.
  • Mechanical ventilation in GBS/MG patients is associated with significant morbidity and mortality.

Conclusions:

  • Objective monitoring and timely intervention, including mechanical ventilation, are critical for managing respiratory failure in GBS and MG.
  • Understanding predictors of ventilation need can optimize patient care and outcomes.
  • Further research into reducing ICU morbidity and mortality in these patients is warranted.